Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

LivaNova helps fill demand for ECMO devices to address COVID-19 in the US

Following the announcement that LivaNova is modifying product indications for some of its cardiopulmonary devices to include extracorporeal membrane oxygenation (ECMO) therapy greater than six hours to treat COVID-19 patients; Azadeh Laffafian, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “According to GlobalData, the need for ECMO has grown […]
Read more

Abbott down 1% in diagnostic revenues but may rally in Q2 with significant number of COVID-19 tests, says GlobalData

Following the announcement that Abbott Laboratories’ Q1 Diagnostics business revenues slightly declined year-over-year; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Within Abbott’s Diagnostics business segment, core laboratory revenues were down 7%. GlobalData expects this hit in revenue to be caused by the general decrease in elective […]
Read more

AMC Health announces new telehealth IVR solutions for COVID-19 patients amid growing demand for virtual healthcare

Following the announcement that AMC Health is launching new telehealth interactive voice response (IVR) monitoring solutions with eviCore healthcare for COVID-19 patients; Azadeh Laffafian, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “The demand for telehealth has increased rapidly during the COVID-19 pandemic as hospitals and clinics attempt to […]
Read more

Medtronic’s minimally invasive business to exhibit slow growth despite high demand for ventilators

Following Medtronic’s announcement on the impact of COVID-19 on its business; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “GlobalData expects Medtronic’s minimally invasive business to exhibit slow growth despite the high demand for certain product lines such as ventilators. Medtronic has increased its production for these […]
Read more

Medicare $100bn expected to relieve financial burden on providers and incentivize high-throughput coronavirus testing, says GlobalData

Following the announcement that the Health and Human Services (HHS) delivered an initial $30bn in relief funding to Medicare providers and suppliers and doubled its payment rate for high-throughput coronavirus testing; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “This injection of cash is a welcome relief […]
Read more

Remote patient monitoring is vital in decreasing COVID-19 hospital demand

Following the announcement that researchers at Massachusetts Institute of Technology (MIT) produced a wireless device that allows healthcare professionals to monitor patients remotely; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “MIT’s device’s artificial intelligence (AI) capabilities enables high-risk patients to be assessed without the need to […]
Read more

Sanofi and Luminostics’ smartphone-based test will disrupt the COVID-19 diagnostics market

Following the announcement by Sanofi and Luminostics to co-develop a smartphone-based self-testing solution for COVID-19; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “There are currently no commercial, over-the-counter COVID-19 self-testing solutions available. Therefore, although Sanofi and Luminostics’ test will not be ready until the end of […]
Read more

bioMérieux revenue expected to continue growth due to COVID-19 respiratory panel test currently in development

Following the announcement that French biotech company bioMérieux reports 21.5% Q1 revenue growth; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “bioMérieux experienced unprecedented Q1 revenue growth due to demand for its molecular biology products used in COVID-19 testing, including its US Food and Drug Administration (FDA) […]
Read more

Quest Diagnostics expected to experience decrease in revenue despite being commercial leader in COVID-19 testing

Following the announcement of Quest, leader in commercial COVID-19 testing in the US, making pay cuts and laying off workers; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Although Quest has performed nearly 800,000 COVID-19 tests, approximately 40% of all COVID-19 testing performed by commercial labs, 40% […]
Read more

3M and Cummins just one of the cross-industry partnerships needed to address equipment shortages

Following the announcement of technology giant 3M Co and engine manufacturer Cummins to join forces in the fight against COVID-19; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “3M Co has ramped up its production of N95 respirators, doubling its normal output. The company is currently manufacturing 100 million N95 respirators per month worldwide, with 35 million of these being produced in the US. Partnering with Cummins is expected to enable a further increase in respirator […]
Read more

Exports of N95 and KN95 from China to ease burden on US manufacturers

Due to the huge shortage of PPE among first responders, healthcare workers and medical staff in the US, it is unlikely that import of KN95 will negatively impact sales of US-made N95 respirators, says GlobalData, a leading data and analytics company. Alison Casey, Medical Devices Analyst at GlobalData, comments: “There is currently an unprecedented shortage of personal protective equipment (PPE) such as N95 respirators in the US and companies such as 3M Co, Honeywell International, Owens & Minor and Prestige […]
Read more

BillionToOne’s Sanger sequencing test is great tool in US’ arsenal against COVID-19 but may not scale well

Following the announcement of a COVID-19 test using Sanger sequencing developed by BillionToOne, a precision diagnostics company; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “BillionToOne’s protocol for a new kind of COVID-19 test takes advantage of a whole different set of instruments, Sanger Sequencers, and chemicals from any existing COVID-19 test currently on the market. The US is in desperate need to increase their testing capacity to effectively […]
Read more

Pharmacists authorized to administer coronavirus tests is not the relief the testing chain needs, says GlobalData

Following the authorization of licensed pharmacists by the US Department of Health and Human Services (HHS) to order and administer coronavirus tests; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “COVID-19 testing is paramount to curbing spread of the disease, yet the US has faced several testing […]
Read more

Keystone Heart may experience rocky start despite receiving CE mark amid COVID-19 pandemic, says GlobalData

Amid the ongoing COVID-19 pandemic, Keystone Heart secured CE approval for its cerebral embolic protection device, the TriGUARD3. However, GlobalData expects that the company will experience a rocky start as a result of the pandemic. In March 2020, Keystone Heart announced that its TriGUARD3 device received CE approval. The cerebral embolic protection device is designed […]
Read more

Medical device companies to strengthen serology testing portfolios to help combat the spread of COVID-19

Following the launch of Bio-Rad Laboratories’ serology assay to detect COVID-19 antibodies; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “As Bio-Rad Laboratories launches an immunoassay, serology testing will become crucial in screening large populations and combating the spread of COVID-19. Immunoassays detect the presence of antibodies […]
Read more

FDA’s new EUA guidance will make it easier for more coronavirus tests to enter market, says GlobalData

Following the US Food and Drug Administration’s (FDA’s) release for new emergency use authorization (EUA) guidance for laboratory developed coronavirus tests; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “The gold standard for diagnosing COVID-19 is a common lab test using the polymerase chain reaction (PCR). While […]
Read more
1 … 45 46 47 48 49 … 51